Breaking News
Investing Pro 0
Close

Pfizer Inc BDR (PFIZ34)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
56.94 +0.14    +0.25%
21:26:00 - Closed. Currency in BRL ( Disclaimer )
  • Volume: 18,219
  • Bid/Ask: 56.82 / 57.44
  • Day's Range: 56.22 - 57.60
Type:  Equity
Market:  Brazil
ISIN:  BRPFIZBDR006 
Pfizer Inc BDR 56.94 +0.14 +0.25%

PFIZ34 Balance Sheet

 
Assess the latest Pfizer Inc BDR balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
31/12
2022
02/10
2022
03/07
2022
03/04
Total Current Assets - 70403 67466 54420
Cash and Short Term Investments - 36132 33312 -
Cash - - - -
Cash & Equivalents - 1298 1780 2470
Short Term Investments - 34825 31524 21427
Total Receivables, Net - 18620 17738 16342
Accounts Receivables - Trade, Net - 16076 15155 13225
Total Inventory - 9513 10454 9979
Prepaid Expenses - - - -
Other Current Assets, Total - 6138 5962 4197
Total Assets - 195350 195290 183841
Property/Plant/Equipment, Total - Net - 15441 15244 15109
Property/Plant/Equipment, Total - Gross - 30372 30213 30467
Accumulated Depreciation, Total - -14931 -14969 -15358
Goodwill, Net - 49441 49891 50211
Intangibles, Net - 28151 29065 29816
Long Term Investments - 13888 18962 20737
Note Receivable - Long Term - 2544 2583 3117
Other Long Term Assets, Total - 10890 7660 7880
Other Assets, Total - 39001 37212 24934
Total Current Liabilities - 44314 47410 39268
Accounts Payable - 6267 6208 5506
Payable/Accrued - - - -
Accrued Expenses - 7261 6330 6547
Notes Payable/Short Term Debt - 1474 4739 394
Current Port. of LT Debt/Capital Leases - 2566 1251 251
Other Current liabilities, Total - 26746 28882 26570
Total Liabilities - 102460 107821 101156
Total Long Term Debt - 32959 34500 35796
Long Term Debt - 32959 34500 35796
Capital Lease Obligations - - - -
Deferred Income Tax - 616 558 655
Minority Interest - 259 261 261
Other Liabilities, Total - 22838 16653 24782
Total Equity - 92890 87469 -
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - 476 476 476
Additional Paid-In Capital - 91359 91183 90844
Retained Earnings (Accumulated Deficit) - 122967 116608 111193
Treasury Stock - Common - -113945 -113939 -113931
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - -7967 -6859 -5897
Total Liabilities & Shareholders' Equity - 195350 195290 183841
Total Common Shares Outstanding - 5612 5593 5591
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFIZ34 Comments

Write your thoughts about Pfizer Inc BDR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email